Squamous Cell Carcinoma of Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Sigvotatug Vedotin in Advanced Solid Tumors [Phase 1]
Phase 1 study of Sigvotatug Vedotin in advanced solid tumors is currently recruiting. The trial targets multiple indications, including non-…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence [Phase 2]
A Phase 2 clinical trial is evaluating a Candida therapeutic vaccine to reduce recurrence in patients with squamous cell carcinoma of the he…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers [NA]
This clinical trial investigates head and neck MRI and tumor microenvironment biomarkers in squamous cell carcinoma of the head and neck; re…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers [NA]
This clinical trial update announces a Phase II randomized study assessing the effects of delayed elective radiotherapy on head and neck MRI…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update indicates that TH9619 is being studied in a Phase 1/2 trial for advanced solid tumors, with recruitment ongoing a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Clinical Trial Evaluating TG4050 in Head and Neck Cancer [Phase 1, Phase 2]
The update describes Transgene's TG4050 in a Phase 1/2 trial for Squamous Cell Carcinoma of Head and Neck, with the study currently active b…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination [NA]
This clinical trial evaluates intraoperative margin assessment using confocal microscopy against reference extemporaneous examination in pat…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck [Phase 3]
A Phase 3 clinical trial update evaluating the addition of nivolumab to cisplatin-based chemoradiation for squamous cell carcinoma of the he…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
A clinical trial update describing a study to quantify systemic immunosuppression to personalize cancer therapy and that the trial is curren…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer [Phase 1, Phase 2]
HYPORT is a Phase I/II study evaluating hypofractionated postoperative radiation therapy for squamous cell carcinoma of the head and neck. T…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy [NA]
An ongoing clinical trial evaluating an app-based approach to recording and optimizing nutritional status in patients with head and neck squ…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC [Phase 2]
Phase 2 neoadjuvant trial evaluating pucotenlimab in combination with TP chemotherapy for locally advanced head and neck squamous cell carci…